31
40
Growth Score
-10 pts
Heat Score
-26 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
393926
A global biopharmaceutical company specialized in research, development and manufacturing of biosimilars for the treatment.
- Timo Liebig: Chief Science Officer
- Silvia Gold: Founder
About the Company
mAbxience is a biotechnology company specialising in the research, development and manufacture of biologic products, mainly biosimilar drugs.
Established in Europe in 2009, they are a multinational group that operates internationally and enjoys a strong presence in the major pharmaceutical markets.
mAbxience is also fully committed to
high-quality products and processes that meet regulatory and technical requirements in all countries in which they operate.
They currently have two fully developed biosimilars already marketed as well as four in the developmental phase.
